X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/with-forty-seven-co-founder-at-the-helm-new-biotech-spinout-launches-to-target-mutations-potentially-linked-to-numerous-diseases/
https://sfbn.org/san-francisco-biotech-news/2021/10/29/gilead-taps-brakes-on-4-9b-bet-after-rivals-failure-pushing-blood-cancer-data-out-to-2022/
https://endpts.com/after-starring-at-ash-last-fall-gileads-new-forty-seven-crew-colors-in-more-promising-data-for-magrolimab-at-asco/
https://www.gilead.com/news-and-press/press-room/press-releases/2020/5/gilead-and-kite-continue-to-advance-next-generation-cancer-therapies-at-2020-american-society-of-clinical-oncology-annual-meeting
https://endpts.com/amid-remdesivir-craze-gilead-finds-time-to-form-another-oncology-pact-looping-in-all-things-nk-cells/
https://www.gilead.com/news-and-press/press-room/press-releases/2020/4/gilead-completes-acquisition-of-forty-seven-inc
https://www.reuters.com/article/us-forty-seven-m-a-gilead-sciences/gilead-buys-forty-seven-for-4-9-billion-to-bolster-cancer-drug-pipeline-idUSKBN20P1PX?il=0
Market Place
Share 
